Zim Laboratories Ltd has reported Consolidated financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 94.6402 crores during the period ended June 30, 2022 as compared to Rs. 106.6909 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. 5.1478 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 7.0302 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. 3.17 for the period ended June 30, 2022 as compared to Rs. 4.33 for the period ended March 31, 2022.
Total Income | ₹ 94.6402 crs | ₹106.6909 crs | -11.29% |
Net Profit | ₹5.1478 crs | ₹7.0302 crs | -26.78% |
EPS | ₹3.17 | ₹4.33 | -26.79% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 94.6402 crores during the period ended June 30, 2022 as compared to Rs.65.3961 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.5.1478 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.1887 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.3.17 for the period ended June 30, 2022 as compared to Rs.0.12 for the period ended June 30, 2021.
Total Income | ₹ 94.6402 crs | ₹65.3961 crs | 44.72% |
Net Profit | ₹5.1478 crs | ₹0.1887 crs | 2,628.03% |
EPS | ₹3.17 | ₹0.12 | 2,541.67% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 236.90 as compared to the previous close of Rs. 225.65. The total number of shares traded during the day was 6044 in over 145 trades.
The stock hit an intraday high of Rs. 236.90 and intraday low of 219.15. The net turnover during the day was Rs. 1403495.00.
Source : Equity Bulls
Keywords
ZimLaboratories
Q1FY23
ResultUpdate